Growing community of inventors

Plainsboro, NJ, United States of America

Charles Pak

Average Co-Inventor Count = 6.17

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 216

Charles PakAndrew S Janoff (5 patents)Charles PakShaukat Ali (5 patents)Charles PakPaul R Meers (5 patents)Charles PakJ Craig Franklin (3 patents)Charles PakDonna J Cabral-Lilly (3 patents)Charles PakTong Shangguan (2 patents)Charles PakRavi K Erukulla (2 patents)Charles PakPatrick L Ahl (1 patent)Charles PakRavi Erukulla (1 patent)Charles PakCharles Pak (5 patents)Andrew S JanoffAndrew S Janoff (80 patents)Shaukat AliShaukat Ali (13 patents)Paul R MeersPaul R Meers (7 patents)J Craig FranklinJ Craig Franklin (13 patents)Donna J Cabral-LillyDonna J Cabral-Lilly (9 patents)Tong ShangguanTong Shangguan (4 patents)Ravi K ErukullaRavi K Erukulla (4 patents)Patrick L AhlPatrick L Ahl (15 patents)Ravi ErukullaRavi Erukulla (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The Liposome Company, Inc. (4 from 115 patents)

2. Elan Pharmaceuticalstechnologies, Inc. (1 from 1 patent)


5 patents:

1. 6339069 - Peptide-lipid conjugates, liposomes and lipsomal drug delivery

2. 6294191 - N-acyl phosphatidylethanolamine-mediated liposomal drug delivery

3. 6143716 - Liposomal peptide-lipid conjugates and delivery using same

4. 6120797 - N-acyl phosphatidylethanolamine-mediated liposomal drug delivery

5. 6087325 - Peptide-lipid conjugates

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…